Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,595,558
+$224,552 QoQ
Shares Held
27,981
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#1,225
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MEANS INVESTMENT CO., INC. holds $25,645,348 across 8 Drug Manufacturers - General names. MRK ranks #4 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
28,110 | $7,139,096 | |
| 2 | ABBV |
AbbVie Inc.
|
22,908 | $5,764,569 | |
| 3 | LLY |
ELI LILLY & Co
|
4,726 | $5,668,506 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
27,981 | $3,595,558 | |
| 5 | NVS |
Novartis AG
|
6,330 | $992,037 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
17,080 | $984,149 | |
| 7 | AMGN |
Amgen Inc
|
2,444 | $885,021 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,879 | $616,412 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,595,558 | 27,981 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,371,006 | 28,024 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $3,055,066 | 29,024 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $2,452,686 | 29,223 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,326,987 | 29,396 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $2,636,700 | 29,375 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $3,048,564 | 30,645 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $3,483,680 | 30,677 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $3,819,477 | 30,852 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $4,128,319 | 31,287 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $3,462,911 | 31,764 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $3,296,047 | 32,016 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $3,794,484 | 32,884 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $3,525,232 | 33,135 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $3,711,277 | 33,450 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $2,882,608 | 33,472 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $3,066,958 | 33,640 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $2,770,090 | 33,761 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $2,599,398 | 33,917 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,679,699 | 35,677 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,854,392 | 36,703 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,825,658 | 36,654 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $2,989,461 | 36,546 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,030,247 | 36,531 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $2,818,447 | 36,447 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,757,759 | 35,843 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||